Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 7 , Pages 711-720, July 2009

Relative Cost-Effectiveness of Treatments for Adolescent Depression: 36-Week Results From the TADS Randomized Trial

Drs. Domino and Foster are with the School of Public Health, University of North Carolina at Chapel Hill; Dr. Vitiello is with the National Institute of Mental Health; Dr. Kratochvil is with the University of Nebraska Medical Center; Dr. Burns is with the Duke University School of Medicine; Drs. Silva and March are with the Duke University Medical Center; and Dr. Reinecke is with Northwestern University

Accepted 19 February 2009.

Disclosure: Dr. Kratochvil has been a consultant or scientific advisor to Eli Lilly and Company, Shire, Cephalon, Organon, AstraZeneca, Boehringer-Ingelheim, Abbott Laboratories, and Pfizer; has received research support from Abbott Laboratories, Cephalon, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, and Ortho-McNeil; has served on the speakers' bureau for Eli Lilly and Company; and has received study drug for an NIMH-funded study from Eli Lilly and Company. Dr. March has been a consultant or scientific advisor to Pfizer, Eli Lilly and Company, Wyeth, GlaxoSmithKline, Jazz Pharmaceuticals, and MedAvante; has held stock in MedAvante; has received research support from Eli Lilly and Company and study drug for an NIMH-funded study from Eli Lilly and Company and Pfizer; and is the author of the Multidimensional Anxiety Scale for Children. Dr. Silva has been a consultant to Pfizer. The other authors report no conflicts of interest.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by contract N01 MH80008 from the National Institute of Mental Health to Duke University Medical Center (John S. March, Principal Investigator). Additional support was received by M.E.D. under K01-MH065639.Dr. Domino had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

PII: S0890-8567(09)60108-8

doi:10.1097/CHI.0b013e3181a2b319

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 7 , Pages 711-720, July 2009

Article Tools

* Image Usage & Resolution